BioCentury
ARTICLE | Clinical News

Plinabulin: Phase I started

August 1, 2016 7:00 AM UTC

BeyondSpring said an investigator began an open-label, U.S. Phase I trial to evaluate 3.5, 20, 30 and 40 mg/m 2 IV plinabulin on days 1, 8 and 15 plus IV Opdivo nivolumab on days 1 and 15 of a 4-week...